Featured News

Glycoengineering technology pioneered by Professor Lai-Xi Wang sublicensed to global pharmaceutical company

Lai-Xi Wang, PhD, Founder and President of GlycoT Therapeutics and UMCP Professor in the Department of Chemistry and Biochemistry, developed the technologies that are the basis for the GlycoT/Daiichi Sankyo license agreement in his lab, first at UMB and later at UMCP. Read more...
Robert E. Fischell Lecture
Join us on Friday, September 25th for a fireside chat on "The Challenges of Drug Development During COVID-19" with Merdad Parsey (B.S. '85, biochemistry), chief medical officer at Gilead Sciences

Recent News